The global neuro monitoring system market is set for remarkable growth, with its valuation expected to soar to USD 9.4 billion by 2032, driven by the increasing number of complex and critical ...

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced significant advancements in the intellectual ...

Clover Health Investments posted strong Q1 growth, with rising membership, CMS tailwinds, and path to profitability by FY ...